Cadrenal Therapeutics, Inc Common Stock

Quarterly Financials

Values in thousands2025-09-302025-06-302025-03-312024-12-31
Revenue
$0
$0
$0
$2
Gross Profit
-5
1
EBITDA
-2,685
-3,733
-3,839
-4,186
EBIT
-2,685
-3,734
-3,845
-4,187
Net Income
-2,685
-3,667
-3,845
-4,187
Net Change In Cash
0
0
0
2
Free Cash Flow
-2,359
-3,025
-4,652
-1,797
Cash
3,860
5,570
7,336
10,017
Basic Shares
2,044
1,961
1,844
1,525

Annual Financials

Values in thousands2024-12-312023-12-31
Revenue
$0
$0
Gross Profit
-1
-1
EBITDA
-10,649
-8,338
EBIT
-10,651
-8,339
Net Income
-10,651
-8,357
Net Change In Cash
0
0
Free Cash Flow
-7,364
-3,533
Cash
10,017
8,402
Basic Shares
1,219
868

Earnings Calls

QuarterEPS
2025-09-30
-$1.31
2025-06-30
-$1.87
2025-03-31
-$2.09
2024-12-31
-$2.55